DOI: 10.1055/s-00000059

Pneumologie

References

Thatcher N, Hirsch FR, Luft AL. et al.
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.

The Lancet Oncol 2015;
16: 763-774

Download Bibliographical Data

Access:
Access: